PT-141
What it is
PT-141 (bremelanotide) is a cyclic heptapeptide derived from Melanotan II, acting mainly on the melanocortin-4 receptor. It has been studied in clinical trials and is supplied here as a research reagent.
Where it has been studied
- Melanocortin-4 receptor pharmacology
- Central nervous system models of sexual behaviour in rodents
- Energy balance studies
Selected literature
- PT-141 PalatinHedlund P et al. · Curr Opin Investig Drugs, 2004 · PMID 15134289
- Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of BremelanotideSimon JA et al. · J Womens Health (Larchmt), 2022 · PMID 35230162
PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.
